Quarterly Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7588359

Concept As at
2022-08-31
2022-03-01 to
2022-08-31
As at
2022-02-28
2021-03-01 to
2021-08-31
As at
2021-08-31
As at
2021-02-28
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
10,179,000,000 JPY
13,215,000,000 JPY
Interest and dividends received
870,000,000 JPY
925,000,000 JPY
Interest paid
-4,000,000 JPY
-6,000,000 JPY
Net cash provided by (used in) operating activities
8,162,000,000 JPY
14,663,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,341,000,000 JPY
-2,216,000,000 JPY
Purchase of investment securities
-5,507,000,000 JPY
-119,000,000 JPY
Proceeds from sale of investment securities
30,000,000 JPY
928,000,000 JPY
Other, net
346,000,000 JPY
26,000,000 JPY
Net cash provided by (used in) investing activities
-17,928,000,000 JPY
-7,164,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-35,000,000 JPY
-41,000,000 JPY
Purchase of treasury shares
0 JPY
0 JPY
Dividends paid
-3,357,000,000 JPY
-3,413,000,000 JPY
Other, net
-185,000,000 JPY
-72,000,000 JPY
Net cash provided by (used in) financing activities
-3,641,000,000 JPY
-3,572,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
5,932,000,000 JPY
2,116,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-7,475,000,000 JPY
6,041,000,000 JPY
Cash and cash equivalents
78,771,000,000 JPY
86,247,000,000 JPY
97,395,000,000 JPY
91,354,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.